More than one million Americans are diagnosed with cancer each year. Nearly 25% of these individuals will develop metastatic brain tumors during the course of their illnesses. Though the number of patients with primary brain tumors is smaller, there is evidence that the incidence of these kinds of brain tumors is rising.
Cleveland Clinic’s Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center serves patients from across the country and around the world. Our specialists, working in partnership with specialists from the Taussig Cancer Institute, offer a full range of advanced treatment options for adults and children with spinal cord and brain tumors, including surgery, chemotherapy, radiotherapy and radiosurgery, and innovative brain tumor clinical trials.
Rose Ella Burkhardt Brain Tumor Center physicians, surgeons, nurses and researchers work as a team, dedicating their lives to treating people with brain tumors. Our researchers are on the cutting edge to determine the mechanisms by which brain tumors occur and the best way to treat them with a minimum of side effects. Our staff physicians are not satisfied with current treatment options available for their patients; most malignant brain tumors cannot be cured. Physicians not only strive to find and use the best combination of current treatments for each patient, but, in collaboration with our researchers, they are actively developing new treatments.
The goal is give our patients hope for improved quality of life through the treatment of brain tumors, while moving forward toward a cure. Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center is a fine combination of research and clinical care: a team working together to offer the best science and technology can offer for brain tumors, one patient at a time.